Yuyu Pharma's Operating Profit Surges 109% in Q2... Net Profit Up 253%
Sales at 54 Billion Won, Operating Profit at 9.2 Billion Won, Net Profit at 7.8 Billion Won on a Separate Basis
All Treasury Shares Cancelled...
Pursuing Process Optimization with AI and Robots
Yuyu Pharma announced that, based on its separate financial statements, sales in the second quarter of this year reached 54 billion won, with operating profit at 9.2 billion won and net profit at 7.8 billion won.
According to a disclosure on August 13, Yuyu Pharma's sales increased by 19.7% compared to the same period last year, while operating profit and net profit rose by 109.3% and 252.9%, respectively.
In June, Yuyu Pharma cancelled all treasury shares it held, including common and preferred shares. The company is pursuing process optimization by utilizing AI-based work tools in its production processes, and plans to complete the introduction of robots and the establishment of a solar eco-friendly energy system in the second half of the year.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Noyong Park, CEO of Yuyu Pharma, said, "We will not be content with achieving a surplus in the second quarter following the first quarter, but will continue to manage key management indicators through cost reduction by converting to a smart factory, aiming for another profitable year."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.